Nutex Health (NASDAQ:NUTX) Shares Gap Up - Should You Buy?

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price gapped up before the market opened on Thursday . The stock had previously closed at $122.29, but opened at $127.50. Nutex Health shares last traded at $118.99, with a volume of 93,844 shares.

Analyst Upgrades and Downgrades

Several analysts have commented on NUTX shares. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. Maxim Group raised their price objective on shares of Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a report on Tuesday, May 20th. Finally, Benchmark raised their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a report on Thursday, May 15th.

Nutex Health Stock Down 2.4%

The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. The company's fifty day simple moving average is $134.51 and its 200 day simple moving average is $87.17. The firm has a market capitalization of $663.86 million, a PE ratio of 10.04 and a beta of -0.04.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping the consensus estimate of ($0.15) by $2.71. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The business had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million.

Insider Buying and Selling

In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the company's stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the purchase, the chief financial officer directly owned 4,888 shares of the company's stock, valued at $399,887.28. The trade was a 25.72% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 36.92% of the company's stock.

Institutional Trading of Nutex Health

A number of large investors have recently made changes to their positions in NUTX. Essex Investment Management Co. LLC grew its holdings in Nutex Health by 45.4% during the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after purchasing an additional 33,024 shares during the last quarter. American Century Companies Inc. purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $1,362,000. Geode Capital Management LLC lifted its position in shares of Nutex Health by 12.6% in the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock worth $1,082,000 after purchasing an additional 3,826 shares during the period. World Investment Advisors purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $217,000. Finally, Russell Investments Group Ltd. purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $672,000. 5.32% of the stock is currently owned by institutional investors.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.